CVE-2015-0398 json
Unspecified vulnerability in the Siebel Life Sciences component in Oracle Siebel CRM 8.1.1 and 8.2.2 allows remote authenticated users to a…
published 2015-01-21 11 y ago modified 2026-06-17 4 mo ago also EUVD-2015-0411
- cvss
- 4.0
- version 2.0, NVD
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 1.1%
- EPSS 1.1% chance of exploitation in 30 days, percentile 66%
- public exploits
- 0
- none known
Summary
Unspecified vulnerability in the Siebel Life Sciences component in Oracle Siebel CRM 8.1.1 and 8.2.2 allows remote authenticated users to affect confidentiality via unknown vectors related to Clinical Trip Report.
Exploit prediction
1.11% chance of exploitation in the next 30 days, higher than 66% of all scored CVEs (FIRST EPSS, 2026-11-09).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| NVD | 2.0 | 4.0 | AV:N/AC:L/Au:S/C:P/I:N/A:N |
References
-
oracle.com
/technetwork/topics/security/cpujan2015-1972971.html
vendor-advisory
-
securityfocus.com
/bid/72207
vdb-entry
-
securitytracker.com
/id/1031578
vdb-entry
-
exchange.xforce.ibmcloud.com
/vulnerabilities/100129
vdb-entry
Sources
- CVE List CVE-2015-0398
- NVD CVE-2015-0398
Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.